Phase 3 Fibromyalgia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with fibromyalgia based on specific medical guidelines (the 2016 ACR diagnostic criteria — confirm with trial site if unsure which criteria your diagnosis was based on)
- You are male or female, aged 18 or older
- You are willing and able to sign a consent form agreeing to take part before any study activities begin
Who may not be able to join:
- You have previously taken part in a clinical trial involving a medication called reboxetine or esreboxetine, or you are currently taking reboxetine for any reason
- You are unable to follow or keep up with the study procedures and requirements
- A doctor involved in the trial has decided, for medical reasons, that it would not be appropriate for you to take part (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 212-332-5061
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time from randomization to loss of therapeutic response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.